Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts
Portfolio Pulse from Benzinga Insights
Evolent Health (NYSE:EVH) has received mixed analyst ratings, with a recent positive shift in average price targets. Analysts have provided a range of price targets from $31.00 to $45.00, with an average of $38.29, up 4.3% from the previous average. The company has shown strong revenue growth and financial health metrics, despite a negative net margin.
October 08, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evolent Health has received a mix of bullish and somewhat bullish ratings from analysts, with a positive shift in average price targets to $38.29. The company's strong revenue growth and financial health metrics are highlighted, despite a negative net margin.
The positive shift in average price targets and the strong revenue growth indicate a favorable outlook for Evolent Health. The mix of bullish ratings and the company's financial health metrics suggest potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100